Trial · NCT00247572
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pharmacodynamic (PD) Parameters: | ||
| Primary | The following parameters will be measured at fixed time intervals post drug and used to compare the | ||
| Primary | effects of various doses of NRP104 with placebo and d-amphetamine sulfate for pharmacodynamic | ||
| Primary | equivalence: | ||
| Primary | (1) Maximum liking scale scores for euphoria measured by DRQS and DRQO | ||
| Primary | (2) Maximum disliking scale scores for dysphoria measured by DRQS and DRQO | ||
| Primary | (3) Maximum scores on the MBG, BG and Amphetamine scales of the ARCI | ||
| Primary | (4) Maximum supine systolic and diastolic blood pressure changes from baseline | ||
| Primary | (5) Maximum orthostatic pulse increases from baseline | ||
| Primary | (6) Spontaneous reports of discomforting subjective effects | ||
| Primary | (7) Adverse events, laboratory tests, physical examination, vital signs and ECG will be collected to | ||
| Primary | assess the safety and tolerability of NRP104. | ||
| Primary | Pharmacokinetic (PK) Parameters | ||
| Primary | The following parameters will be calculated using non-compartmental analysis for d-amphetamine and | ||
| Primary | intact | ||
| Primary | NRP104: AUC0-24, Cmax , Tmax. | ||
| Primary | • AUC0-24: Area under the drug concentration-time curve from time zero to 24 hours post dose. | ||
| Primary | • Cmax: Maximum observed drug concentration from zero hour to 24 hours post dose. | ||
| Primary | • Tmax: Time at which Cmax occurs. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00247572/registered